Skip to content
About Us
Team
Board
Business Model
Pipeline
BRM421 for Dry Eye Disease
BRM423 for Corneal Damage Repair
BRM424 for Neurotrophic Keratitis
BRM521 for Treatment of Osteoarthritis
Investors
News
Stock Quotes
Company Documents
Corporate Sustainability
Corporate Governance
Stakeholders
News
Career
Contact Us
繁體中文
About Us
Team
Board
Business Model
Pipeline
BRM421 for Dry Eye Disease
BRM423 for Corneal Damage Repair
BRM424 for Neurotrophic Keratitis
BRM521 for Treatment of Osteoarthritis
Investors
News
Stock Quotes
Company Documents
Corporate Sustainability
Corporate Governance
Stakeholders
News
Career
Contact Us
繁體中文
選單
2023/01/06
Non-Confidential Corporate Slide Deck
Post navigation
Next
Post
Corporate overview
